Lysosomal Disease Treatment Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Lysosomal Disease Treatment Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Lysosomal Disease Treatment Market by Disease: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Gauchers

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Fabry Disease

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Pompe Disease

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Mucopolysaccharidosis(MPS)

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.6  Others

4.6.1   Current Trend and Analysis

4.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Lysosomal Disease Treatment Market: by Route of Administration: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Oral Route Administration

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Intravenous Route of Administration

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Lysosomal Disease Treatment Market by End User: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.2  Hospitals

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.3  Clinics

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.4  Others

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Lysosomal Disease Treatment Market by Geography: Market Size and Forecast, 2019 - 2028 

7.1  Overview

7.1.1   Global Lysosomal Disease Market Year-on-Year Growth, by region 2020 – 2028 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3.2        By Disease

7.2.3.3        By Route of Administration

7.2.3.4        By End User

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.4.2        By Disease

7.2.4.3        By Route of Administration

7.2.4.4        By End User

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.5.2        By Disease

7.2.5.3        By Route of Administration

7.2.5.4        By End User

7.3    Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3.2        By Disease

7.3.3.3        By Route of Administration

7.3.3.4        By End User

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.4.2        By Disease

7.3.4.3        By Route of Administration

7.3.4.4        By End User

7.3.5   France

7.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.5.2        By Disease

7.3.5.3        By Route of Administration

7.3.5.4        By End User

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.6.2        By Disease

7.3.6.3        By Route of Administration

7.3.6.4        By End User

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.7.2        By Disease

7.3.7.3        By Route of Administration

7.3.7.4        By End User

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.8.2        By Disease

7.3.8.3        By Route of Administration

7.3.8.4        By End User

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3.2        By Disease

7.4.3.3        By Route of Administration

7.4.3.4        By End User

7.4.4   India

7.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.4.2        By Disease

7.4.4.3        By Route of Administration

7.4.4.4        By End User

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.5.2        By Disease

7.4.5.3        By Route of Administration

7.4.5.4        By End User

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.6.2        By Disease

7.4.6.3        By Route of Administration

7.4.6.4        By End User

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast

7.5.3   South America

7.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.3.2        By Disease

7.5.3.3        By Route of Administration

7.5.3.4        By End User

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.4.2        By Disease

7.5.4.3        By Route of Administration

7.5.4.4        By End User

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.5.2        By Disease

7.5.5.3        By Route of Administration

7.5.5.4        By End User

Chapter 8        Company Profiles

8.1  Acteloin Pharmaceuticals Ltd.

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  Amicus Therapeutics

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  Arena Pharmaceutical Inc.

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  Astellas Pharma

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  Astrazeneca

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  Biomarin Pharmaceuticals Inc.

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  Eli Lilly and Company

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  Lexicon Pharmaceutical Inc.

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4     Financials

8.8.5     Recent Developments

8.9  Merck & Co. Inc.

8.9.1     Company Overview

8.9.2     Product Portfolio

8.9.3     Business Strategies

8.9.4     Financials

8.9.5     Recent Developments

8.10       Novo Nordis A/S

8.10.1   Company Overview

8.10.2   Product Portfolio

8.10.3   Business Strategies

8.10.4   Financials

8.10.5   Recent Developments

8.11       Sangamo Therapeutics, Inc.

8.11.1   Company Overview

8.11.2   Product Portfolio

8.11.3   Business Strategies

8.11.4   Financials

8.11.5   Recent Developments

8.12       Sanofi Genzyme

8.12.1   Company Overview

8.12.2   Product Portfolio

8.12.3   Business Strategies

8.12.4   Financials

8.12.5   Recent Developments

8.13       Shire

8.13.1   Company Overview

8.13.2   Product Portfolio

8.13.3   Business Strategies

8.13.4   Financials

8.13.5   Recent Developments